Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.

Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI.

Clin Cancer Res. 2019 Mar 15;25(6):1786-1794. doi: 10.1158/1078-0432.CCR-18-0200. Epub 2018 Aug 28.

PMID:
30154229
2.

MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.

Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM; ACRIN 6657 Trial Team and I-SPY Investigators Network.

AJR Am J Roentgenol. 2018 Jun;210(6):1376-1385. doi: 10.2214/AJR.17.18323. Epub 2018 Apr 30.

PMID:
29708782
3.

Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).

Tsuchiya K, Mori N, Schacht DV, Sheth D, Karczmar GS, Newstead GM, Abe H.

J Magn Reson Imaging. 2017 Dec;46(6):1738-1747. doi: 10.1002/jmri.25694. Epub 2017 Mar 10.

PMID:
28295791
4.

Fast bilateral breast coverage with high spectral and spatial resolution (HiSS) MRI at 3T.

Medved M, Li H, Abe H, Sheth D, Newstead GM, Olopade OI, Giger ML, Karczmar GS.

J Magn Reson Imaging. 2017 Nov;46(5):1341-1348. doi: 10.1002/jmri.25658. Epub 2017 Mar 6.

5.

Breast density estimation from high spectral and spatial resolution MRI.

Li H, Weiss WA, Medved M, Abe H, Newstead GM, Karczmar GS, Giger ML.

J Med Imaging (Bellingham). 2016 Oct;3(4):044507. doi: 10.1117/1.JMI.3.4.044507. Epub 2016 Dec 28.

6.

MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM; ACRIN Trial team ISPY-1 Investigators.

J Magn Reson Imaging. 2017 Jul;46(1):290-302. doi: 10.1002/jmri.25560. Epub 2016 Dec 16.

7.

Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis.

Pineda FD, Medved M, Wang S, Fan X, Schacht DV, Sennett C, Oto A, Newstead GM, Abe H, Karczmar GS.

Acad Radiol. 2016 Sep;23(9):1137-44. doi: 10.1016/j.acra.2016.04.008. Epub 2016 Jun 6.

8.

Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies.

Sardanelli F, Newstead GM, Putz B, Jirakova Trnkova Z, Trimboli RM, Abe H, Haverstock D, Rosenberg M.

Invest Radiol. 2016 Jul;51(7):454-61. doi: 10.1097/RLI.0000000000000254.

PMID:
26840494
9.

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators.

Radiology. 2016 Apr;279(1):44-55. doi: 10.1148/radiol.2015150013. Epub 2015 Dec 1.

10.

Using MRI to detect and differentiate calcium oxalate and calcium hydroxyapatite crystals in air-bubble-free phantom.

Mustafi D, Fan X, Peng B, Foxley S, Palgen J, Newstead GM.

Phys Med. 2015 Dec;31(8):1075-1079. doi: 10.1016/j.ejmp.2015.07.141. Epub 2015 Sep 29.

11.

Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0 T: a pilot study.

Pineda FD, Medved M, Fan X, Ivancevic MK, Abe H, Shimauchi A, Newstead GM, Karczmar GS.

Br J Radiol. 2015 May;88(1049):20150021. doi: 10.1259/bjr.20150021. Epub 2015 Mar 18.

12.

Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.

Shimauchi A, Abe H, Schacht DV, Yulei J, Pineda FD, Jansen SA, Ganesh R, Newstead GM.

Eur Radiol. 2015 Aug;25(8):2470-8. doi: 10.1007/s00330-015-3635-1. Epub 2015 Feb 20.

PMID:
25698353
13.

Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer.

Yamaguchi K, Abe H, Newstead GM, Egashira R, Nakazono T, Imaizumi T, Irie H.

Breast Cancer. 2015 Sep;22(5):496-502. doi: 10.1007/s12282-013-0512-0. Epub 2014 Jan 9.

PMID:
24402638
14.

Decision making for breast lesions initially detected at contrast-enhanced breast MRI.

Yamaguchi K, Schacht D, Sennett CA, Newstead GM, Imaizumi T, Irie H, Abe H.

AJR Am J Roentgenol. 2013 Dec;201(6):1376-85. doi: 10.2214/AJR.12.8953.

PMID:
24261380
15.

Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.

Yamaguchi K, Schacht D, Newstead GM, Bradbury AR, Verp MS, Olopade OI, Abe H.

AJR Am J Roentgenol. 2013 Nov;201(5):1155-63. doi: 10.2214/AJR.12.9707.

PMID:
24147491
16.

Axillary staging of breast cancer: what the radiologist should know.

Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM.

Radiographics. 2013 Oct;33(6):1589-612. doi: 10.1148/rg.336125060. Review.

PMID:
24108553
17.

Do we really need contrast agents?

Medved M, Karczmar GS, Newstead GM.

Eur J Radiol. 2012 Sep;81 Suppl 1:S99-100. doi: 10.1016/S0720-048X(12)70040-2. No abstract available.

PMID:
23083622
18.

Radiologists' performance in the ACR Breast MR With Guided Biopsy course.

Lee CI, Grauke LJ, Sandhir V, Demartini WB, Newstead GM, Peacock S, Lehman CD.

J Am Coll Radiol. 2013 Nov;10(11):854-8. doi: 10.1016/j.jacr.2013.03.012. Epub 2013 May 25.

PMID:
23714721
19.

Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer.

Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA.

AJR Am J Roentgenol. 2013 Mar;200(3):696-702. doi: 10.2214/AJR.12.9036.

PMID:
23436865
20.

Classification of breast lesions pre-contrast injection using water resonance lineshape analysis.

Wood AM, Medved M, Bacchus ID, Al-Hallaq HA, Shimauchi A, Newstead GM, Olopade OI, Venkataraman SS, Ivancevic MK, Karczmar GS.

NMR Biomed. 2013 May;26(5):569-77. doi: 10.1002/nbm.2893. Epub 2012 Nov 20.

21.

Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment.

Abe H, Shimauchi A, Fan X, River JN, Sattar H, Mueller J, Karczmar GS, Newstead GM.

J Appl Clin Med Phys. 2012 Nov 8;13(6):3802. doi: 10.1120/jacmp.v13i6.3802.

22.

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators.

Radiology. 2012 Jun;263(3):663-72. doi: 10.1148/radiol.12110748.

23.

T(2)∗ relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland.

Hipp E, Fan X, Jansen SA, Markiewicz EJ, Vosicky J, Newstead GM, Conzen SD, Krausz T, Karczmar GS.

Med Phys. 2012 Mar;39(3):1309-13. doi: 10.1118/1.3684950.

24.

Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images.

Medved M, Fan X, Abe H, Newstead GM, Wood AM, Shimauchi A, Kulkarni K, Ivancevic MK, Pesce LL, Olopade OI, Karczmar GS.

Acad Radiol. 2011 Dec;18(12):1467-74. doi: 10.1016/j.acra.2011.07.017. Epub 2011 Oct 1.

25.

The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.

Jansen SA, Shimauchi A, Zak L, Fan X, Karczmar GS, Newstead GM.

J Magn Reson Imaging. 2011 Jun;33(6):1382-9. doi: 10.1002/jmri.22567.

26.

Combined use of T2-weighted MRI and T1-weighted dynamic contrast-enhanced MRI in the automated analysis of breast lesions.

Bhooshan N, Giger M, Lan L, Li H, Marquez A, Shimauchi A, Newstead GM.

Magn Reson Med. 2011 Aug;66(2):555-64. doi: 10.1002/mrm.22800. Epub 2011 Apr 26.

27.

Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.

Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM.

Eur Radiol. 2011 Jul;21(7):1374-82. doi: 10.1007/s00330-011-2080-z. Epub 2011 Feb 17.

PMID:
21327872
28.

In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.

Jansen SA, Conzen SD, Fan X, Markiewicz E, Krausz T, Newstead GM, Karczmar GS.

NMR Biomed. 2011 Aug;24(7):880-7. doi: 10.1002/nbm.1643. Epub 2011 Jan 25.

29.

Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.

Shimauchi A, Giger ML, Bhooshan N, Lan L, Pesce LL, Lee JK, Abe H, Newstead GM.

Radiology. 2011 Mar;258(3):696-704. doi: 10.1148/radiol.10100409. Epub 2011 Jan 6.

PMID:
21212365
30.

Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study.

Jansen SA, Fan X, Medved M, Abe H, Shimauchi A, Yang C, Zamora M, Foxley S, Olopade OI, Karczmar GS, Newstead GM.

Phys Med Biol. 2010 Oct 7;55(19):N473-85. doi: 10.1088/0031-9155/55/19/N02. Epub 2010 Sep 21.

PMID:
20858914
31.

Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.

Chen W, Giger ML, Newstead GM, Bick U, Jansen SA, Li H, Lan L.

Acad Radiol. 2010 Jul;17(7):822-9. doi: 10.1016/j.acra.2010.03.007.

32.

Echo-planar spectroscopic imaging (EPSI) of the water resonance structure in human breast using sensitivity encoding (SENSE).

Medved M, Ivancevic MK, Olopade OI, Newstead GM, Karczmar GS.

Magn Reson Med. 2010 Jun;63(6):1557-63. doi: 10.1002/mrm.22332.

33.

MR imaging of ductal carcinoma in situ.

Newstead GM.

Magn Reson Imaging Clin N Am. 2010 May;18(2):225-40, viii. doi: 10.1016/j.mric.2010.02.004. Review.

PMID:
20494308
34.

Breast cancers not detected at MRI: review of false-negative lesions.

Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM.

AJR Am J Roentgenol. 2010 Jun;194(6):1674-9. doi: 10.2214/AJR.09.3568.

PMID:
20489112
35.

Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.

Bhooshan N, Giger ML, Jansen SA, Li H, Lan L, Newstead GM.

Radiology. 2010 Mar;254(3):680-90. doi: 10.1148/radiol.09090838. Epub 2010 Feb 1.

36.

MR-directed ("Second-Look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings.

Abe H, Schmidt RA, Shah RN, Shimauchi A, Kulkarni K, Sennett CA, Newstead GM.

AJR Am J Roentgenol. 2010 Feb;194(2):370-7. doi: 10.2214/AJR.09.2707.

PMID:
20093598
37.

Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.

Jansen SA, Paunesku T, Fan X, Woloschak GE, Vogt S, Conzen SD, Krausz T, Newstead GM, Karczmar GS.

Radiology. 2009 Nov;253(2):399-406. doi: 10.1148/radiol.2533082026.

38.

Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMRI of the breast.

Jansen SA, Fan X, Yang C, Shimauchi A, Karczmar G, Newstead GM.

Acad Radiol. 2010 Jan;17(1):24-30. doi: 10.1016/j.acra.2009.06.015.

PMID:
19836270
39.

Fourier component imaging of water resonance in the human breast provides markers for malignancy.

Medved M, Newstead GM, Fan X, Du YP, Olopade OI, Shimauchi A, Zamora MA, Karczmar GS.

Phys Med Biol. 2009 Oct 7;54(19):5767-79. doi: 10.1088/0031-9155/54/19/007. Epub 2009 Sep 9.

40.

Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

Jansen SA, Conzen SD, Fan X, Markiewicz EJ, Newstead GM, Karczmar GS.

Breast Cancer Res. 2009;11(5):R65. doi: 10.1186/bcr2357.

41.

Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.

Jansen SA, Shimauchi A, Zak L, Fan X, Wood AM, Karczmar GS, Newstead GM.

AJR Am J Roentgenol. 2009 Sep;193(3):832-9. doi: 10.2214/AJR.08.2025.

42.

Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage.

Medved M, Newstead GM, Abe H, Olopade OI, Shimauchi A, Zamora MA, Karczmar GS.

Magn Reson Imaging. 2010 Jan;28(1):16-21. doi: 10.1016/j.mri.2009.05.022. Epub 2009 Jul 22.

43.

Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.

Abe H, Schmidt RA, Kulkarni K, Sennett CA, Mueller JS, Newstead GM.

Radiology. 2009 Jan;250(1):41-9. doi: 10.1148/radiol.2493071483. Epub 2008 Oct 27.

PMID:
18955508
44.

Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.

Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, Newstead GM, Chmura SJ.

Cancer. 2008 Nov 1;113(9):2408-14. doi: 10.1002/cncr.23872.

45.

Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.

Jansen SA, Conzen SD, Fan X, Krausz T, Zamora M, Foxley S, River J, Newstead GM, Karczmar GS.

Phys Med Biol. 2008 Oct 7;53(19):5481-93. doi: 10.1088/0031-9155/53/19/014. Epub 2008 Sep 9.

46.

DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Giger M, Newstead GM.

Med Phys. 2008 Jul;35(7):3102-9.

47.

Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study.

Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Newstead GM.

Magn Reson Med. 2008 Apr;59(4):747-54. doi: 10.1002/mrm.21530.

48.

US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it.

Abe H, Schmidt RA, Sennett CA, Shimauchi A, Newstead GM.

Radiographics. 2007 Oct;27 Suppl 1:S91-9. doi: 10.1148/rg.27si075502. Review.

PMID:
18180238
49.

Breast lesions incidentally detected with CT: what the general radiologist needs to know.

Harish MG, Konda SD, MacMahon H, Newstead GM.

Radiographics. 2007 Oct;27 Suppl 1:S37-51. doi: 10.1148/rg.27si075510. Review.

PMID:
18180233
50.

Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.

Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS.

Radiology. 2007 Dec;245(3):684-91.

PMID:
18024450

Supplemental Content

Loading ...
Support Center